• FAQs
  • Glossary
Close

FAQs

Why are some conditions more suitable for gene and cell therapies than others?
There is an approved treatment available for my condition - why can't I receive it?
How to look for approved medicines?
How are medicines developed and approved?

See all FAQs

Close

Glossary

Adeno-associated virus (AAV)
Adenovirus
Adult stem cells
Antibody
Antigen
Base editors
Cas9 nuclease
Chimeric Antigen Receptor (CAR)
Chromosome
Clinical trial

See full Glossary

EMA Regulatory Science to 2025 - strategic reflection

Page 31 and 35 of the report revises existing patient engagement methodology. 

Last updated:

Back to top
Did you find the content on this page useful? If not, you can leave us a message so we can improve Send us your thoughts